SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028583
Filing Date
2018-11-08
Accepted
2018-11-08 16:33:41
Documents
51
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rcus-10q_20180930.htm 10-Q 1585949
2 EX-10.1 rcus-ex101_134.htm EX-10.1 23059
3 EX-10.2 rcus-ex102_135.htm EX-10.2 88821
4 EX-31.1 rcus-ex311_9.htm EX-31.1 17673
5 EX-31.2 rcus-ex312_7.htm EX-31.2 17737
6 EX-32.1 rcus-ex321_6.htm EX-32.1 9197
7 EX-32.2 rcus-ex322_8.htm EX-32.2 9228
  Complete submission text file 0001564590-18-028583.txt   5086353

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rcus-20180930.xml EX-101.INS 975614
9 XBRL TAXONOMY EXTENSION SCHEMA rcus-20180930.xsd EX-101.SCH 36584
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rcus-20180930_cal.xml EX-101.CAL 41062
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rcus-20180930_def.xml EX-101.DEF 94448
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20180930_lab.xml EX-101.LAB 287877
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20180930_pre.xml EX-101.PRE 199992
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 650-489-9000
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38419 | Film No.: 181170157
SIC: 2834 Pharmaceutical Preparations